Latest filing published 03 Mar 2025 for Cyclo Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Randall M. Toig is a declared insider of Cyclo Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 20 filings, for trades running from 23 May 2018 to 27 February 2025.
Every open-market trade on record is a purchase: 6 purchases worth €111k, and no sale. The totals do not cover 3 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 13 share grants.
The median purchase comes to €9,080. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 3 March 2025, the filings show a share grant in Cyclo Therapeutics, Inc. The clock since the last published purchase (14 December 2020) now reads 2,139 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations